Peptide Comparison
VesilutevsHuman Chorionic Gonadotropin (HCG)
Tissue-specific dipeptide bioregulator (Glu-Asp) that epigenetically normalizes urogenital function through chromatin remodeling, anti-inflammatory cytokine regulation, and smooth muscle tone restoration in the bladder and prostate
A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.
At a Glance
Quick
comparison
Dose Range
Vesilute
20–40 mg
Human Chorionic Gonadotropin (HCG)
250–2000 IU
Frequency
Vesilute
Once daily
Human Chorionic Gonadotropin (HCG)
Twice weekly
Administration
Vesilute
Oral (capsule/tablet)
Human Chorionic Gonadotropin (HCG)
Subcutaneous injection
Cycle Length
Vesilute
12+ weeks
Human Chorionic Gonadotropin (HCG)
Ongoing/indefinite
Onset Speed
Vesilute
Gradual (3-4 weeks)
Human Chorionic Gonadotropin (HCG)
Moderate (1-2 weeks)
Evidence Level
Vesilute
Moderate human trials (Phase 1-2)
Human Chorionic Gonadotropin (HCG)
Strong human trials (Phase 3 or FDA approved)
Efficacy
Benefit
ratings
Bladder Health
Prostate Support
Tissue Repair
Fertility Preservation
Testicular Health
Hormone Balance
Technical Data
Compound
specifications
Vesilute
Molecular Formula
C9H14N2O7
Molecular Weight
262.2 g/mol
Half-Life
Short plasma half-life typical of dipeptides (minutes); biological effects persist for weeks to months through epigenetic gene regulation; metabolized to constituent amino acids via standard pathways
Bioavailability
High oral bioavailability for a dipeptide — absorbed intact by intestinal peptide transporter PepT1 (SLC15A1); ultra-short structure enables efficient cellular uptake and nuclear penetration
CAS Number
3918-84-1
Human Chorionic Gonadotropin (HCG)
Molecular Formula
C1105H1770N318O336S26 (approximate)
Molecular Weight
36,700 g/mol (approximately)
Half-Life
24-36 hours
Bioavailability
High when injected subcutaneously or intramuscularly
CAS Number
9002-61-3
Protocols
Dosing
tiers
Vesilute
Human Chorionic Gonadotropin (HCG)
Applications
Best
suited for
Vesilute
Supporting bladder health and urinary function in aging individuals
Vesilute is particularly well-suited for individuals focused on supporting bladder health and urinary function in aging individuals. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Bioregulatory approach to benign prostatic hyperplasia (BPH) management
Vesilute is particularly well-suited for individuals focused on bioregulatory approach to benign prostatic hyperplasia (bph) management. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Reducing chronic urogenital inflammation through epigenetic mechanisms
Vesilute is particularly well-suited for individuals focused on reducing chronic urogenital inflammation through epigenetic mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Complementing standard urological treatments with peptide bioregulator therapy
Vesilute is particularly well-suited for individuals focused on complementing standard urological treatments with peptide bioregulator therapy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Human Chorionic Gonadotropin (HCG)
Fertility Preservation During TRT
If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men.
Preventing Testicular Atrophy
Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function.
Hypogonadotropic Hypogonadism
If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility.
Post-Cycle Therapy (PCT)
After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol.
Safety Profile
Side
effects
Vesilute
Common
- Mild gastrointestinal discomfort
- Increased urinary frequency initially
- Mild headache
- Minor fatigue
Uncommon
- Injection site irritation
Serious
- No documented serious adverse effects
Human Chorionic Gonadotropin (HCG)
Common
- Injection site reactions
- Headache
- Water retention
Uncommon
- Gynecomastia
- Mood changes
- Acne
Serious
- Blood clots
Research Status
Safety
& evidence
Vesilute
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Vesilute (fibroin-derived peptide from Bombyx mori silk) demonstrates favorable biocompatibility from cosmetic ingredient testing with minimal allergic or irritant potential despite its animal protein origin. Limited systemic absorption occurs topically, confining effects to dermal layers with low risk of systemic toxicity. Silk-derived peptides have been used in cosmetics for >20 years without documented serious adverse events in published literature. Theoretical hypersensitivity risk exists for individuals with silk allergy, though cross-reactivity with purified peptide is low.
Contraindications
- xKnown hypersensitivity to peptide bioregulators or constituent amino acids (glutamic acid, aspartic acid)
- xPregnancy and breastfeeding — insufficient reproductive safety data
- xActive urinary tract infection requiring antibiotic treatment — treat infection first
- xBladder or prostate malignancy — proliferative effects of peptide bioregulators may be contraindicated
Human Chorionic Gonadotropin (HCG)
Evidence Level
Strong human trials (Phase 3 or FDA approved)
FDA Status
FDA approved for other use
Safety Overview
HCG has been used medically for over 80 years with a well-established safety profile. When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. Serious side effects are rare when HCG is used under medical supervision.
Contraindications
- xHormone-sensitive cancers (prostate, breast)
- xPrecocious puberty in children
- xKnown allergy to HCG or any component
- xPregnancy (in therapeutic male contexts)
- xUntreated thyroid or adrenal disorders
Decision Guide
Which is
right for you?
Choose Vesilute if...
- Supporting bladder health and urinary function in aging individuals
- Bioregulatory approach to benign prostatic hyperplasia (BPH) management
- Reducing chronic urogenital inflammation through epigenetic mechanisms
- Complementing standard urological treatments with peptide bioregulator therapy
Choose Human Chorionic Gonadotropin (HCG) if...
- Fertility preservation during TRT
- Maintaining testicular size and function
- Natural testosterone stimulation
- Post-cycle therapy recovery